-
Mashup Score: 0
Sunnie Kim, MDUniversity of Colorado Cancer CenterJeffrey Olsen, MDUniversity of Colorado Cancer CenterNCCN Medical Education Disclosure PolicyIt is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24…
Source: education.nccn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1NCCN Pharmacy Updates: Novel Therapies for the Treatment of Metastatic Breast Cancer | NCCN Continuing Education - 2 year(s) ago
Melissa Armitage, PharmD, BCOPMoffitt Cancer CenterNCCN Medical Education Disclosure PolicyIt is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards…
Source: education.nccn.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tune in on October 27 for the NCCN Pharmacy Updates webinar: Novel Therapies for the Treatment of Metastatic Breast Cancer. Register now: https://t.co/IAJTtWUTJ3 @MoffittNews #CE #CPE #CME #BCSM #metastaticbreastcancer #BreastCancerAwareness #BreastCancerAwarenessMonth https://t.co/fGTWKTYKwN
-
-
Mashup Score: 0NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022 - 2 year(s) ago
The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This month's @NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for #LungCancer Screening: https://t.co/Afa6lUC2nb Earn free #CME #CNE #CPE https://t.co/vY23el0Rk2
-
-
Mashup Score: 0
Estimated Time 1.50 hours Release Date Sep 30, 2021 Expiration Date Mar 01, 2023 Method…
Source: lms.mliace.orgCategories: Latest Headlines, PayerTweet-
Need help optimizing insulin therapy to improve outcomes for your patients with T1 and T2D? New #CME/#NCPD/#CPE activity, 1.5 max. credits/contact hours: https://t.co/ZPhlwktc8g. #diabetes cc @mli_ace @TheEndoSociety https://t.co/335CI5d1bV
-
-
Mashup Score: 1NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 - 2 year(s) ago
The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton’s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective chemotherapy-free option for patients with previously untreated or relapsed/refractory CLL/SLL. Undetectable minimal residual disease after the end of…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This month's @NCCN Guidelines Insights discuss updates to #NCCNGuidelines for CLL/SLL specific to use of chemotherapy-free treatment options for treatment-naïve & relapsed/refractory disease: https://t.co/EjPjqii3wN #BloodCancer #lymsm #leusm Earn free #CME #CNE #CPE https://t.co/P01WcltYhe
-
-
Mashup Score: 0
Estimated Time 1.50 hours Release Date Sep 30, 2021 Expiration Date Mar 01, 2023 Method…
Source: lms.mliace.orgCategories: Latest Headlines, PayerTweet-
Need help optimizing insulin therapy to improve outcomes for your patients with T1 and T2D? New #CME/#NCPD/#CPE activity, 1.5 max. credits/contact hours: https://t.co/ZPhlwktc8g. #diabetes cc @mli_ace @TheEndoSociety https://t.co/biSKNhMLaT
-
-
Mashup Score: 3
To describe an outbreak of carbapenemase-producing Enterobacterales CPE) in a COVID-19 intensive care unit and discuss key infection control measures enabling prompt termination of the cluster.
Source: Journal of Hospital InfectionCategories: Infectious Disease, Latest HeadlinesTweet-
New study describes an outbreak of carbapenemase-producing Enterobacterales #CPE in a #COVID19 intensive care unit and discuss key infection control measures enabling prompt termination of the cluster. https://t.co/lZnUxIzSx8 https://t.co/oujnvzEgls
-
-
Mashup Score: 0AMCP eLearning Days | AMCP.org - 2 year(s) ago
AMCP eLearning Days are educational experiences featuring the hottest topics in managed care pharmacy. As an exclusive benefit of membership, registration is free for AMCP members! Select sessions will be accredited for continuing pharmacy education (CPE) credit.
Source: www.amcp.orgCategories: Latest Headlines, PayerTweet-
We’re less than one week away from eLearning Days! Reserve your spot now for this exciting virtual event offering free CPE: https://t.co/aPBzGeaAH4 #pharmacy #CPE #managedcare https://t.co/l8FQGGEIuw
-
-
Mashup Score: 3NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022 - 2 year(s) ago
Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL) and nodular lymphocyte–predominant HL are the 2 main types of HL. The cure rates for HL have increased so markedly with the advent of modern treatment options that overriding treatment considerations often relate to long-term toxicity. These NCCN Guidelines Insights discuss the recent updates to the NCCN…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Insights into the recent updates to #NCCNGuidelines for #HodgkinLymphoma re: #radiationtherapy dose constraints and management of advanced-stage and relapsed/refractory classic Hodgkin Lymphoma: https://t.co/YMgHENr3qk #lymsm Earn Free #CME, #CNE, and #CPE https://t.co/GZnSGGGYUx
-
-
Mashup Score: 1Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes - 2 year(s) ago
Disclosure As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an accredited continuing education activity to disclose…
Source: www.managingmyeloma.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @MediComOncology: 📢1 week away! Ask the Expert REGISTER➡️https://t.co/5MOMa46AFC 🆓LIVE #CME #CNE #CPE webinar🖥️with expert @szusmani…
-
Join us on November 9 for the Monthly Oncology Tumor Board: Esophageal and Esophagogastric Junction Cancers: Postoperative Therapy in Patients with Residual Disease. Register now: https://t.co/qlKypTxvQF @CUCancerCenter #CE #CME #CNE #CPE #EsophagealCancer https://t.co/T67psFQaKy